Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spino

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Canadian Medical Association Journal|March 24, 2010
Adverse biochemical and clinical consequences of furosemide administrationE M Sellers, M Spino
Pharmacotherapy|January 1, 1991
Colchicine: a state-of-the-art reviewM Levy, M Spino, S E Read
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Dissolution and in vivo evidence of differences in reference products: impact on development of generic drugsM Spino, Y C Tsang, R Pop
American Journal of Hospital Pharmacy|September 1, 1978
Effect of adverse drug reactions on the length of hospitalizationM Spino, E M Sellers, H L Kaplan
Journal of Pharmaceutical Sciences|November 1, 1978
Determination of flucytosine in tablets by differential pulse polarographyF W Teare, R N Yadav, M Spino
Pharmaceutical Research|January 3, 2006
Transport kinetics of iron chelators and their chelates in Caco-2 cellsXi-Ping Huang, M Spino, J J Thiessen
British Journal of Clinical Practice. Supplement|January 1, 1984
Bioavailability of Somophyllin-CRT capsulesA F Isles, S Leeder, M Spino, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 10, 2001
High-performance liquid chromatographic assays for a second-generation novel oral iron chelator (APCP363) and their application to pharmacokinetic studies in ratsF Guo, J J Thiessen, A Tesoro, et al.
Biopharmaceutics & Drug Disposition|January 1, 1983
Human platelet response to three salicylate dosage formsJ J Thiessen, H Grad, S M Macleod, et al.
Medical Hypotheses|March 3, 1999
Hypothetical framework for enhanced renal tubular secretion of drugs in cystic fibrosisC Woodland, D Blowey, S Ito, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Canadian Medical Association Journal|March 24, 2010
Adverse biochemical and clinical consequences of furosemide administrationE M Sellers, M Spino
Pharmacotherapy|January 1, 1991
Colchicine: a state-of-the-art reviewM Levy, M Spino, S E Read
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Dissolution and in vivo evidence of differences in reference products: impact on development of generic drugsM Spino, Y C Tsang, R Pop
American Journal of Hospital Pharmacy|September 1, 1978
Effect of adverse drug reactions on the length of hospitalizationM Spino, E M Sellers, H L Kaplan
Journal of Pharmaceutical Sciences|November 1, 1978
Determination of flucytosine in tablets by differential pulse polarographyF W Teare, R N Yadav, M Spino
Pharmaceutical Research|January 3, 2006
Transport kinetics of iron chelators and their chelates in Caco-2 cellsXi-Ping Huang, M Spino, J J Thiessen
British Journal of Clinical Practice. Supplement|January 1, 1984
Bioavailability of Somophyllin-CRT capsulesA F Isles, S Leeder, M Spino, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 10, 2001
High-performance liquid chromatographic assays for a second-generation novel oral iron chelator (APCP363) and their application to pharmacokinetic studies in ratsF Guo, J J Thiessen, A Tesoro, et al.
Biopharmaceutics & Drug Disposition|January 1, 1983
Human platelet response to three salicylate dosage formsJ J Thiessen, H Grad, S M Macleod, et al.
Medical Hypotheses|March 3, 1999
Hypothetical framework for enhanced renal tubular secretion of drugs in cystic fibrosisC Woodland, D Blowey, S Ito, et al.
Pageof 5